ProShare Advisors’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,927
Closed -$122K 2208
2025
Q1
$122K Sell
10,927
-3,056
-22% -$33.8K ﹤0.01% 1795
2024
Q4
$144K Buy
+13,983
New +$135K ﹤0.01% 1980

Other funds holding ENFN

ProShare Advisors's ENFN Position: Q2 2025 in Review

ProShare Advisors sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 10,927 shares — an estimated $122K sold.

ProShare Advisors first reported a position in ENFN in Q4 2024 and held it in 2 quarters. The position peaked at $144K in Q4 2024. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • ProShare Advisors reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • ProShare Advisors sold 10,927 Enfusion, Inc. shares in Q2 2025, an estimated $122K.
  • ProShare Advisors first reported a position in Enfusion, Inc. in Q4 2024 and held it in 2 quarters.
  • ProShare Advisors's Enfusion, Inc. position peaked at $144K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on ProShare Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.